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A full discussion of key approaches, chemical and enzymatic, for sialyl Lewis x(SiLeX), a cell
surface carbohydrate ligand involved in cell-cell interaction, has been presented.
Chemical methods can provide variants of Sil.e" -type structures, however they constitute a
synthetic challenge. The enzymatic approaches, which have attractive features on the other hand face
limitations with regard to the availability of glycosyltransferases, expensive sugar nucleotides, and
product inhibition, although some of these limitations have in part been overcome by using multi-
enzyme systems. Future developments in solid-phase oligosaccharide synthesis will not be only
fascinating but lead to efficient syntheses which will be high yielding and also flexible enough to
incorporate the structural variations necessary for obtaining new antiinflammatory drugs.
1 Introduction
The discovery identifying the oligosaccharide
nature of the cell surface ligands involved in a
wide variety of life processes and the clear
establishment of the key roles played by these
carbohydrate components in many biological
events, such as adhesion to glycoproteins, has lent
weight to the notion that carbohydrates play
important roles in cellular recognition and many
other physiological functions. A plethora of cell-
surface oligosaccharides have been characterised
and found to participate in cell-cell interactions.
For example, the tetrasaccharide, sialyl Lewis
x(SiLeX), a-Neu5Ac-(2~3)-I3-D-Gal-(1~4)-[a-L-
Fuc-(1~3)J-I3-GlcNAc 1 (cf. Figure 1) which has
been found on the surface of some tumour and
cancer cells, mediates the adhesion of neutrophils
to endothelial cells (endothelium leucocyte
adhesion molecule, ELAM 1), an initial event in
many inflammatory responses 1. The biochemical
mechanism of the cell-adhesion process involves
binding by SiLeX to the glycoprotein E-selectin.
This cell-adhesion molecule, which is synthesized
and expressed on endothelial cell surfaces in
response to cytokines, recognizes and binds Sile"
and other structurally related oligosaccharides
found on leucocyte surfaces'. Hence, considerable
effort has gone into developing syntheses of Sile"
analogues, derivatives and mimetics both as
ligands of E-selectin and as alternative potent
structures with improved therapeutic efficacy, with
the aim of developing improved methods for
tumour diagnosis and the treatment of
inflammation. Although research activity over
almost a decade has resulted in the development of
many new chemical and chemoenzymatic methods
for the synthesis of these oligosaccharides,
obtaining them in synthetically useful manner still
remains a challenge.
Chemical glycoxylation methods for obtaining
Sil.e" type compounds generally involve stiching
an appropriate monosaccharide donor, with its
anomeric centre activated in some fashion, to an
acceptor whose anomeric centre is differentially
blocked. Of the three glycosidic linkages in these
oligosaccharides the most difficult to synthesize is
that of a-neuraminic acid (5-acetamido-3,5-
dideoxy-p-glycero- a-D-Galacto-2-hexulopyrano-
sonic acid, a-Neu5Ac). Construction of this
glycosidic bond is plagued by side reactions, low
yields, and difficulty in generating the desired
stereochemistry at the newly formed anomeric
centre. Enzyme catalysed glycosylation,
particularly the use of glycosyltransferases by
analogy with the biosynthetic glycosidic bond
formation" of Sil.e" (Figure I), is a promising tool,
but to date, not a good alternative to chemical
synthesis. This review is not intended to be a








Figure I-Biosynthetic glycosidic bond formation of SiLe'
ref 2c (i) formation of lactosamine (LacNAc, Gal-p-
(1~4)GlcNAc-P-OR), (ii) a-sialylation of LacNAc, (iii) a-
fucosylation of a-Neu5Ac-(2~3)Gal-p-(1 ~4)GIc NAc-p-
OR.
comprehensive treatment of glycosylation
reactions. These will be discussed only briefly with
reference to the synthesis of different types of
glycosidic linkages embedded in the title
oligosaccharide structures. The principal aim of
this article is to highlight the synthetic methods
that have been responsible for stimulating the
renaissance in this area. For the sake of brevity,
original long synthetic sequences from the
literature have been omitted and/or shortened.
More detailed information can be obtained by
consulting : the cited literature and references
therein. The following subjects are considered.
Chemical syntheses--especially with reference to
the difficult neuraminic acid glycosylation-
through the use of different donors, and their
limitations, enzymatic syntheses (glycosyl-
transferase reactions and the use of glycosidases),
and some recent modifications with respect to the
title oligosaccharide synthesis. Also described
herein are the most recent advances and their
potential for obtaining SiLeXand its derivatives
and analogues.
2 Chemical Synthesis
2.1 Background. Excellent treatises' cover the
topic of O-glycosylations in depth. Although a
discussion of all types of glycosylations is not the
aim of this article, nevertheless, before discussing
the synthesis of Sil.e" type oligosaccharides, a
brief review of the most critical of the three
methods for glycosylation of Neu5Ac, using
different types of donors, is worthwhile.
Glycosylation using neuraminic acid donors is
still a challenging task" owing to the inherent
structural features of this molecule. First, because
it possesses a C-3 deoxy structure, the formation of
the 2,3-dehydro derivative 3 can occur along with
the normal glycoside 4 when the anomeric OH
group is attached (Figure 2). Also its shape
precludes the possibility of a directing and/or
assisting effect from an auxiliary group at C-3.
Consequently, classical stereocontrolling tactics in
oligosaccharide synthesis, such as in situ
anomerization or neighbouring acyloxy group
participation cannot be applied to this particular
type of glycosylation. Furthermore, during
glycosylation, the presence of a carboxylic acid
functionality at the quaternary anomeric position
electronically disfavours oxonium ion formation,
an intermediate necessary for almost all types of
glycosylation reactions. In addition, its spacial
extension may further sterically restrict glycoside
bond formation. Inspite of these difficulties, an
improved method, in terms both of yield and ease
of performance of the reaction, was developed
using halides4b•s of Neu5Ac as donors and
activation by mercury or silver salts. This method
-c,
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Figure 2--Glycosylation ofNeuo Ac. Formation ofnonnal glycoside and 2,3-dehydro derivative
(3) 2.3-dehydro derivative
furnished the desired product, only in modest
yield, with a-stereochemistry at the glycosidic
bond, particularly with secondary hydroxy groups
such as thio" 5-7 or seleno? 8 in donors derived
form halogenated NeuSAc derivatives was
considered. However, the synthesis of the required
starting materials and the removal of the auxiliary
groups after the reaction limited the scope and
usefulness of this method.
Thioglycosides' of NeuSAc 9 have been used as
NeuSAc donors. Although, sialylation of many
acceptors has been efficiently accomplished, the
requirement of at least equimolar amounts of
thiophilic reagents (promotors) is discouraging. A
preference due to the nitrile effect, towards the
formation of equatorial glycosides (a-product in
NeuSAc) under kinetically controlled conditions, is
a well documented process", When applied to thio-
group-activated NeuSAc derivatives such as
xanthates":" 10 or alkylthiols, a-selectivity was
improved but not the yield. Recently, it has been
demonstrated that phosphates and phosphites':":"
11,12-which are easily and directly attachable
moieties at the anomeric hydroxy group of
NeuSAc derivatives--can be used as donors for
efficient sialylation and result in better yields and
formation of glycosides (cf. Figure 3) with the
desired regio- and stereoselectivity. These results
are listed in Table I.
2.2 Synthesis of SiLeX and analogues. The first
efficient chemical synthesis 13 of Sil.e" was
reported in 1991. It uses a neighbouring phenylthio
(PhS) group as an auxiliary both for facilitating the
reaction and controlling the stereochemistry
(a/1f3:3/2) at the new glycosidic bond with
NeuSAc (Scheme I). The requisite fragments 13-16
were synthesised from D-Galactose, D-gluco-
samine, L-fucose, and NeuSAc, respectively. The
reaction followed the sequence:formation of
LacNAc derivative 17, its a-fucosylation to obtain
the trisaccharide 18, and finally n-sialylation to
render SiLeX in 63% yield-readily available in
pure form for biological investigations.
Hasegawa and co-workers described the first
total synthesis" of a SiLeX glycolipid (Scheme II).
The trisaccharide 19 was u-fucosylated with
methyl 2,3,4-tri-O-benzyl-l-thio-j3-L-fucopyrano-
side 20 in the presence of dimethyl(methylthio)-
sulfonium triflate (DMTST) and reductively ring-
opened to obtain 21. Glycosylation of 21 with 22
followed by modifications furnished SiLeX
hexasaccharide 23 in 81% yield. The donor 22, in
turn, was obtained by initial DMTST-promoted
glycosylation of methyl u-thioglycoside of
NeuSAc with 2-(trimethylsilyl)ethyl 6-0-benzoyl-
j3-D-galactopyranoside, followed by benzoylation,
acetylation, and finally its conversion into methyl
j3-thioglycoside 22. In addition, this approach
allowed the formation of gangliosides GM3, GM4,
and other sialosides.
Among the naturally occurring ELAM 1 binding
oligosaccharides, sialyl dimeric Lewis x(SidiLeX)
28, which occupies a prominent position due to its
molecular complexity and potential as a highly
potent substrate, was identified as a tumour-
associated oligosaccharide and thus was expected
to serve as a marker for tumour cell targeting. The
first syntheses of Sidil.e" and a functionalized
SiLeX analogue 26 were reported by Nicolaou and
coworkers 15 using a previously developed
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(5) RI-SPb. R'.Br. R'-R4.Bn
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(8) RI=SeI'II.R'=F. R'.R4.Ac
(9) RI.H. Rl-sMe. R'.R4.Ac
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Table I-Reactivity of Neu5Ac donors (D) with acceptor (A,R50H) (Figure 3)
Solvent(s) Reaction D:A Catalyst Selectivity
temperature ratio (eq.) (a:p)
(0C)
CCI. 20 I: 1.6 Hg(CNMI.6)
HgBr2 (0.5) a
CCI. 40 I: 1.6 -do- 30:1
CCI. 20 1:1.6 AgOTf(2.0)
SnCI.(2.0) 3.5:1
CCI4 r.t 1:2.1 AgOTf(2.0)
SnCI2(2.0) a
CH3CN -40 1.6:1 NIS (2.0)
TfOH (0.2) a
CH3CN -15 1:2 DMTST(2.0) a
CH3CN -30 I: 1.5 NIS (1.0)
TfOH (0.2) a
CH3CN/CH2CI2 -60 2:1 AgOTf(2.0)
MeSBr(2.0) a
CH3CN -40 I: 1.5 TMS01J (0.1) a













synthesis of SiLeX,and PhS as auxiliary group. The
synthetic sequence involved the use of a common
trisaccharide 24 for obtaining the acceptor 2S for
sialylation with Neu5AC donor S in order to
synthesize the SiLeX derivative 26 (Scheme III).
The latter, in turn, was used as a donor for
obtaining 28 by glycosylating it with acceptor 27
obtained from 24 (Scheme IV).
Interest in Sil.e" was also fuelled by the
possibility that small molecular analogues bearing
the pertinent structural features of SiLeX might
serve as antagonists of ELAMl. Thus, a concise
chemical route to differently functionalised
congeners of the LeX series was reported by
Danishefsky and coworkers" (Scheme V). The
merit of this approach stems from the use of D-
glucal 29 and n-lactal derivatives as precursors.
The resulting Sil.e" glycal 30, an analogue of
SiLeX,was in a straight forward manner converted
into SiLeX employing stannyl alkoxide addition to
the glycal-derived iodo sulfonamides'i".
The 3'-sulfate analogues of Sil.e" (another cell
surface oligosaccharide) and SiLeX were found by
Feizi and coworkers'v" to be even better ligands











Scheme II-First total synthesis of Sil.e" glycolipid, ref. 14
for E-Selectin than the parent compounds.
However, an equimolar mixture of 3' -sulfated
Sil.e' and 3' -sulfated SiLe' tetrasaccharides
derived from ovarian cystadenoma glycoprotein
was used to establish this, clearly precluding any
assumption as to the relative potencies of the two
compounds. To answer this question In part,
terminal 3' -sulfated Le" trisaccharide 33 was
synthesized I 8 as depicted in Scheme VI. This
procedure gave 33 in a remarkable 80% yield.
Because of the importance of sulfated Le" and
sulfated Lea ligands in adhesion processes and in
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Scheme III-Synthesis of Sil.e" derivative, ref.IS
(24) Reagents
(26)
reagents and modifications -
OH OH
(28)
Scheme IV-Synthesis of Si(diLe'), ref. IS
order to overcome the difficulty of obtaining
useful amounts from natural sources the total
syntheses of sulfated LeX tetrasaccharides 38 and
their truncated analogous trisaccharides 39 were
developed". These compounds were constructed
from the key intermediates 34, 35 and 36 obtained
from D-Galactose. n-glucosamine, and L-fucose,
respectively. A f3-linked disaccharide precursor
was obtained via a o-glucosamine-derived
glycosyl donor and an acceptor D-galactose
derivative, using standard. Mukaiyama conditions
(AgCI04-SnClz) (Scheme VII). Further protection-
deprotection sequences gave the disaccharide 37
which was then coupled with the Galactosyl
fluoride donor 34 to form the trisaccharide which
in turn was fucosylated and subsequently sulfated
to give the sulfated Le" tetrasaccharide 38 in 80%
overall yield. Following a similar strategy a
synthesis of the corresponding trisaccharide 39
was also accomplished.








TBDPS ~ t-butyldipbmyl siJyl











MBN = 4-methoxy benzyl
Scheme VI-Synthesis of3'-sulfated Lea, ref 18
To. obtain the sulfated Lea tetrasaccharide 42 and
the corresponding trisaccharide 43, a different
strategy was developed (Scheme VIII). The
common trisaccharide intermediate 40a was first
obtained by coupling of the Galactosyl fluoride
donor with a glucosamine derivative, using
standard Mukaiyama-Suzuki (Cp2HfCI2-AgOTt)
conditions, followed by the sequence:
regioselective ring - opening, coupling of the
fucose residue using 36 anB conversion of the
resulting trisaccharide into its fluoride. For the
tetrasaccharide synthesis this trisaccharide
intermediate was coupled with a Galactose unit 41.
Subsequent deprotection and sulfation yielded the
desired sulfated tetrasaccharide 42 in 40% overall
yield. For trisaccharide 43, the common
trisaccharide intermediate 40a was first
glycosylated with benzyl alcohol to obtain 40b and
then subjected to a similar sequence of reactions as
depicted above whereupon 43 was obtained.
A recent discovery that the terminal N-
acetylglucosamine residue of SiLeX oligosac-
charide could be replaced by n-glucopyranose
without losing its selectin binding activity,
stimulated the development of two methods for the
stereocontrolled synthesis':" of this Sil.e'
analogue. The strategy adopted for these syntheses
(Scheme IX) involved the initial formation of
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trisaccharides 44 and 45 by coupling an a-fucose
residue to selectively protected 2-(trimethylsilyl)-
ethyl(SE) I3-lactoside, respectively. The resulting
trisaccharides 44 and 45 obtained after protecting
group manipulation, upon glycosylation with 2-
thiophenyl Neu5Ac donors 46 using N-
iodosuccinamide-triflic acid (NIS- TfDH)7 and








triflate (TMSOTf)12 furnished respectively the
tetrasaccharides 47 and 48, after removal of the
protecting groups. Sulfation of the trisaccharide 49
and deprotection gave the sulfated Le" analogue
50. These sequences constituted short and efficient
syntheses of tetrasaccharide and sulfated trisac-
charide analogs of Sil.e" and sulfated LeX
trisaccharide from the easily available I3-lactosides.
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Scheme IX-Synthesis of Sil.e" and 3'-sulfated Le" analogs, ref7 and 12
The 13C-Iabelled Sil.e" derivatives have also
been synthesized for NMR spectroscopic studies.
These showed that the SiLeX group has a folded,
low energy conformation" in which the L-fucose
residue lies above the n-Galactose. Thus, it
appears that the Sil.e'tetrasaccharide forms a well-
defined hydrophilic surface along the Neu5Ac-
Gal-Fuc structural unit, while a hydrophobic
region exists below the Neu5Ac-Gal-GlcNAc
structural moiety. Althoughthe structures of all the
selections (E, L, P) have not yet been determined,
the chemical strategies described above will surely
help in the design and synthesis of a series of
SiLe'/SiLe' analogues such as glucal derivatives,
di(SiLe') derivatives sulfated Levl.e" tetra- and
trisaccharide derivatives, and other unnatural
oligosaccharides, which may answer many of the
existing questions on the mechanism of action of
binding and may provide potentially new
carbohydrates with enhanced antiinflammatory
properties.
2.3 Limitations of the chemical synthesis. (1)
Multiple protection and deprotection steps are
required, which make it difficult to scale-up the
procedures (2) Stereoselectivity of the
glycosylation reaction is a major problem. (3) Side
reactions and low yields of desired products limit
the scope,
3 Enzymatic Synthesis
An efficient oligosaccharide synthesis must
meet a number of criteria, viz. it must be efficient,
highly regio and stereo selective, and feasible (and
safe) on a large scale. The enzymatic approach to
obtain SiLeX in vitro is based in principle upon the
in vivo biosynthesis of this oligosaccharide". For
the in vitro enzymatic synthesis of SiLeX and
related oligosaccharides there are three strategies
from which it is possible to choose the Leloir
pathway, which makes use of glycosyltransferases
and utilizes monosaccharide activated as glycosyl
ester of nucleoside mono or diphosphates as
glycosyl donors. The' second makes use of
activated donors such as glycosyl phosphates in the
non-Leloir pathway. The third approach involves
the use of glycosidases (glycosyl hydrolase
enzymes). These enzymes cleave the glycosyl
bond, but can also form glycosyl bonds in a
'reverse-hydrolytic' manner under equilibrium or
kinetic controlled conditions. Paulson and Wong
have used glycosyltransferases in an exciting
small-scale enzyme catalysed synthesis of
SiLeX21.
Before describing these enzymatic approaches
for preparing SiLeX, a brief description of
glycosylrransferases and glycosidases is presented.
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3.1 Glycosyltransferases. Glycosyltransferases
utilize glycosyl esters of nucleoside phosphates as
activated monosaccharide donors. These enzymes
are highly regio-and stereospecific with respect to
the formation of the new glycosidic linkage.
Unfortunately, however, many of these enzymes
are not readily available, and those which are
available usually have high substrate specificity.
The following glycosyltransferases have been used
in the synthesis of Sil.et-type structural units.
3.1.1 13-1,4-Galactosyltransferase (EC
2.4.1.22)(13-1,4-GaIT)22. For the formation of
LacNAc unit, the transfer of a 13-0-
Galactopyranosyl (I3-o-Gal) group from uridine
diphosphate Galactose (UDP-Gal) to 0-4 of a
terminal non-reducing residue of N-acetyl-l3-o-
glucosamine (GJcNAc) is catalysed by 13-1,4-GaIT.
This enzyme can be obtained from bovine milk
and is commercially available. Several derivatives
of UDP-Gal have been examined as substrates for
13-1,4-Gal T.
3.1.2 Sialyltransferases (Sial T)22. Sialyltrans-
ferases catalyse the transfer of sialyl residues in
. oligosaccharides, generally either at the 3- or 6-
position of terminal l3-o-Gal or N-acetyIGalacto-
samine (GaINAc) residues, by the reaction of
donor cytidine 5'-monophosphate N-acetylneur-
aminic acid (CMP-Neu5Ac) with an acceptor.
Only two of the many species of SialT have been
widely utilized (Figure 4) for in vitro enzymatic
oligosaccharide synthesis (No species of Sial T is
readily available). For a comprehensive treatment
of this subject the reader is referred to two highly
informative review articles'"".
3.1.2.1 a-2,6-Sialyltransferase (EC.2.4.99.I)
(a-2,6-Sial T)22. This enzyme catalyses the
transfer of the Neu5Ac unit to the primary position
of o-Gal in a LacNAc residue. Besides LacNAc,
some other structural variants of the donor
molecule are also accepted. Several a-Neu5Ac-
(2-+6)Gal (3-(l-+4)GJcNAc derivatives have been
CMP-Neu5Ac ROH
Figure 4---<l-Sialylationusing Sial T
+
GDP-Fuc + ROH
Figure 5-a-Fucosylation using a-I ,3-Fuc T
synthesized starting from GIcNAc derivatives and
applying in sequence the Galactosylation and
sialylation reactions.
3.1.2.2 a-2,3-Sialtransferases (EC.2.4.99.4)(a-
2,3-Sial T)22This transferase catalyses the transfer
of Neu5Ac to 0-3 of the o-Gal residue and is
responsible for the formation of sequences like a-
Neu5Ac(2-+3)Gal (3-(l-+3)GJcNAc (More
favoured), and a-Neu5Ac(2-+3)Gal (3-
(l-+4)GJcNAc (less favoured). These are typical
terminal sequences in O-linked oligo saccharides of
glycoproteins, gangliosides, and glycolipids.
3.1.3 Fucosyltransferases (Fue T)22. In addition
to Sil.e", many biologically important
oligosaccharides, e.g. blood group substances and
tumour-associated antigens, are fucosylated. From
the proposed model of SiLe"-E Selectin
interaction"; it seems that apart from the carboxyl
function of Neu5Ac, and 4- and 6-0H of the
Galactose residue, all three hydroxyl functions of
fucose are essential for the binding and hence the
biological activity of SiLeX and the related
compounds. Also, fucosylation is the final
modification of oligosaccharide structures like
Sil.e" in biosynthetic pathway. These enzymes
require guanidine diphosphate fucose (GDP-Fuc)
as donor substrate a-I,3-Fucosyltransferase (a-
1,3-Fuc T) has been used for L-fucosylation of
GJcNAc in LacNAc and of a-Neu5Ac(2-+3)-
LacNAc to furnish LeX and SiLeX structural
units":" (Figure 5).
Enzymatic synthesis of SiLeX with in situ
cofactor regeneration has been reported by Wong
and co-workers. The strategy adopted was based
upon the biosynthesis of Sil.e". The operation
basically comprises four cycles (i) the formation of
LacNAc [Gal-(3-(l-+4)GlcNAc(3-0R] derivative
51 from glucose-I-phosphate (GlcI-P) and
GlcNAc derivative mediated by (3-1,4-Gal T
(50%), (ii) formation of Neu5Ac from N-
acetylmannosamine (ManNAc) catalysed by
Neu5Ac-OR + CMP
a-l,3-Fuc T•• Fuc-OR + GDP
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Scheme X-Synthesis of Sil.e" using multienzyme synthesis, ref 21
Neu5Ac aldolase (quantitative), (iii) the formation
of a-Neu5Ac-(2--t3)-Galf3-(l--t4)GlcNAcl3-0R 52
from LacNAc and Neufi Ac catalyzed by CMP-
Neu5Ac synthetase and a-2,3-Sial T (24%), and
(iv) the formation of Sil.e", a-Neu5Ac-(2--t3)-
Gall3-(1--t4)-Fuca-(l--t3)GlcNAcl3~OR, catalysed
by GDP-Fuc generating enzyme and a-l,3-Fuc T
(68%) (Scheme X).
The key step of Scheme X appears to be the
synthesis of LacNAc and its sialoside. Two
multi enzyme systems for the synthesis of LacNAc
have been reported with in situ cofactor
regeneration. One starts with Glc-l-P and uses
UDP-Glc pyrophosphorylase and UDP-Gal 4-
epimerase UDP-Gal is generated from UDP-Glc
with UDP-Gal 4-epimerase. A second procedure
uses Gal instead of Glc-l-P as a donor and UDP-
Glc pyrophosphorylase Galactokinase and Gal-l-
P-uridyltransferase. Wong and co-workers used a
large scale synthesis of LacNAc using f3-1,4-Gal T
in which UDP-Gal and UDP-Glc were regenerated
in situ UDP-Gal was obtained by epimerisation of
UDP-Glc using UDP-Gal 4-epimerase. The
equilibrium was shifted in favour of UDP-Gal by
transferring it onto GlcNAc with [3-1,4-Gal T
resulting in the formation of LacNAc. UDP-Glc in
turn was obtained by reacting Glc-1P (produced by
conversion of Glc-6-P by phosphoglucomutase)
with UTP in the presence of UDP-Glc
pyrophosphorylase. For sialoside synthesis, a
similar multienzyme system utilizing a-2,3-Sial T
for sialylation has been reported. It starts with
Neu5Ac, LacNAc, phospho(enol)pyruvate (PEP)
and catalytic amount of adenosine triphosphate
(ATP) and cytidine monophosphate (CMP).
Sialylation of LacNAc was accomplished with
CMP-Neu5Ac and a-2,3-Sial T. The released CMP
underwent conversion into cytidine diphosphate
(CDP), and then cytidine triphosphate (CTP), and
finally into CMP-Neu5Ac. Using this system a-
Neu5Ac-(2--t3)Gall3-(I--t4)GlcNAcf3-0-allyl, as
well as the labelled trisaccharides were prepared.
In addition, lactal Gall3-(1--t4)-glucal was
sialylated to obtain a-Neu5Ac-(2--t3)-Gall3-
(l--t4)-glucal which could also be convertedl6b into
Sil.e". The fucosylation of a-Neu5Ac-
(2--t3)LacNAc was conducted using GDP-Fuc as
donor and a-l,3-Fuc T. GDP-Fuc was in turn
prepared from mannosamine-l-phosphate (Man-l-
P) and GDP in the presence of PEP. The enzymes
pyruvate kinase and guanosine 5'-
diphosphomannose (GDP-Man) pyrophosphor-
ylase, subsequently converting GDP-Man into
GDP-Fuc.
These in situ regenerating systems for obtaining
Sil.e" avoid the tedious separations and expensive
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preparations of sugar nucleotides and the
stoichiometric use of nucleosrde rmenomers or
diphosphates that are known inhibitors of the
corresponding glycosyltransferases at rvery low
concentrations. Since glycosyltransferases,
especially Sial T, show some flexibility in their
specificity towards glycosyl donors and acceptors,
the synthesis of a variety of Sil.e" analogues is
possible.
3.2 Glycosidases. Excellent review articles" on
the chemistry, the mechanism of action, and the
inibition of these enzymes are available. In this
review, only use of the glycosidases in the
synthesis of Sil.e" -type (partial) structures is
discussed, since no total synthesis of Sil.e-type
compounds employing only glycosidases has been
achieved to date. Compared to glycosyltrans-
ferases, glycosidases have the advantage of their
wider availability and lower cost. Also, the use of
expensive sugar nucleoside donors is not required.
The mechanisms of action (Figure 6) for the
formation of glycosidases involves initial
formation of a glycosyl enzyme and the subsequent
transfer of glycosyl group to another sugar.
Glycosyl transfers using glycosidases can be
performed under either equilibrium or kinetically-
controlled conditions, the latter method being the
most favoured. The equilibrium approach reverses
the glycoside hydrolysis reaction by combining a
free monosaccharide and a nucleophile. However,
the equilibrium constant for the reaction greatly
favours hydrolysis over glycoside formation. To
influence the equilibrium in glycosidase-catalysed
reactions, strategies such as product precipitation,
addition of water-miscible organic cosolvents, use
of biphasic systems, high substrate concentrations,
etc. have been investigated, but a high yielding
+ EnzH
glycoside synthesis has not yet been achieved
because of significant product hydrolysis. There
are presumably two conformational inversions in
the mechanism shown in Figure 6, so that the
anomeric configuration of the newly formed
glycosidic bond is the same as that of the donor.
The kinetic approach (transglycosylation) for
the synthesis of oligosaccharides makes use of
activated . glycoside donors. From a practical
viewpoint, the use of commercially available (3-
Galactosidases for the synthesis of LacNAc by
using' the transglycosylation reaction has been
reported".
Another attractive application of (3-
Galactosidase in the coupling of (3-D-Gal
derivative 53 to the glucal 54 affording the
regioselective (3-(1-+3) linked disaccharide 55, a
subunit of Lea and Sil.e", has been reported"
recently. In this process 56 was obtained as an
additional product. The disaccharide 55 could then
be c-fucosylated or a-sialylated and fucosylated to
afford Lea or Sil.e" analogues, respectively.
Synthesis was favoured kinetically over the
thermodynamically favoured hydrolysis pathway
(Scheme XI) by using an activated donor to
achieve glycosidic bond formation.
The attachment of Neu5Ac group to
oligosaccharides through an a-linkage has been
intensively studied by chemical synthetic methods
and by enzymatic methods using Sial T. However,
inherent difficulties of the Sial T method, viz.
laborious isolations, extreme instability,
pronounced acceptor substrate specificity, and the
requirement of CMP-Neu5Ac as donor allow the
synthesis of only a limited number of sialoside
sequences, thus restricting the synthetic potential
of the method. However, in contrast to the use of
+ ROH
+ Sug~-OH Glycosyl transfer.. Suglif-O-SuglifI + EnzH
1.H20 (Hydrolysis)
Sugar' + Enz
Figure 6--Glycosidase mediated approach to oligosaccharide (glycosyl transfer and hydrolysis).
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OH,_OH
~oHO-S:::~O-O-NO,OH




Scheme XI-p-Galactosidase mediated coupling of p-D-Gal to glucal, ref 26
(56)
sialyltransferases alone, condensation of a-
Neu5Ac and acceptors in the presence of sialidases
appears promising. In one such approach the
desired products have been obtained at the expense
of another sialoside which is used as a donor. This
method" makes use of trans-sialidase enzyme
from Trypanosoma cruzi which exhibits the unique
property of catalysing reversible transfer of
Neu5Ac from the donor substrate of the sequence
a-Neu5Ac-(2~3)-j3-0Rl to virtually any
glycoside acceptor of the type j3-Gal-OR2 to
furnish a new sialoside a-Neu5Ac-(2~3)Gal-OR2.
Unfortunately, all the sialidases, studied ~o far,
have been obtained from different sources," and
different substrates have been used in each study.
Thiem and co-workers have reported" the
synthesis of 2~3 and 2~6 linked isomers of a-
Neu5Ac-(3-Gal-OCH3 in a 1:10 ratio employing an
immobilized sialidase for reverse hydrolysis, under
the reaction conditions of high temperature and
high concentration. In contrast to this reverse
hydrolysis technique, other trans-sialylations have
been conducted as lower temperatures and using
activated Neu5Ac as donor for a variety of
sialylations. In all these cases, the formation of
2~6 isomers predominated. Addition of fucose
residue, however, diminishes the capacity to
inhibit formation of cc-Neuo.Ac-fucosyllactose/",
Eventhough glycosidases exhibit high selectivity
for the anomeric configuration of the newly
formed bond, regioselective synthesis, especially
in the case of Sil.e" -type compounds employing
glycosidases, is inherently limited due to the
preponderant formation of 1~6 linkages over the
desired 1~3 or 1~4 linkages. Thus, a synthesis
employing glycosidases, especially one capable of
transferring Neu5Ac to position 3-0H of the (3-0-
Gal or Le" structure, without the accompanying
hydrolysis of the product SiLeX, is still awaited.
4 Modifications
Apart from the lack of control of regioselectivity
in glycosidase-catalysed enzymatic transfor-
mations, low yields are also a problem due to
significant hydrolysis of the product, which is a
substrate for these enzymes. This process is also
thermodynamically favoured. To control the
problem of product hydrolysis, a combination
enzyme system has been reported by Wong" for
the synthesis of the trisaccharide 52. Using (3-
Galactosidase for reversible glycosyl exchange of
lactose and GlcNAc, a new disaccharide 51, is
obtained which is transformed into 52 by
sialyltransferase-catalysed reaction. Since 52 is not
a substrate .for glycosidase, the process is
irreversible. This strategy could provide flexibility
for designing future oligosaccharide syntheses.
Another exciting approach, also from the
Wong's group is the solid phase synthesis of
glycopeptides" and oligosaccharides. This. uses
peptide bonds produced by chemical means and
glycosidic bonds formed enzymatically with the
help of glycosyltransferases. in one such synthesis
the solid support used was aminopropylsilica
which is compatible with both aqueous and non
aqueous solvents and provides a high density
functional groups and a large surface area. The
first step involves inclusion of a hexaglycine
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(2) R= peptide
!Solid phase synthesis
Scheme XII-Solid phase synthesis of SiLeX.ref. 31.
spacer to the support, from which the glycosyl
acceptor was prepared by adding the appropriate
glycopeptide. This was followed by Galacto-
sylation using [3-1,4-Gal T and the conventional
UDP-Gal as acceptor. Subsequent transformations
including a-2,3-sialylation using a-2,3-sialyltrans-
ferase and CMP-Neu5Ac furnished the sialylated
product. The sialylated product was then cleaved
from the solid support and fucosylated enzyma-
tically to furnish a new route to Sil.e" glycopeptide
(Scheme XII).
5 Overview
Recent investigations of chemical and
enzymatic syntheses of ligands of E-Selectin have
been summarized in this review". The validity of
the various methodologies employed in this area
still remains a concern. The prime demand of
glycobiologists is the development of high yielding
efficient syntheses of pure oligosaccharides for use
in biological assays and in the development of new
drugs. Chemical methods can provide variants of
Sil.e/-type structures," however they constitute a
synthetic challenge. The enzymatic approaches,
which have attractive features on the other hand
face limitations with regard to the availability
glycosyltransferases, expensive sugar nucleotides,
and product inhibition, although some of these
limitations have in part been overcome by using
multienzyme systems. Future developments in
solid-phase oligosaccharide synthesis will be
fascinating. It is reasonable to suppose that the full
potential of the described methods has yet to be
realised, so that the future will see the
development of efficient syntheses which will be
not only high yielding but also flexible enough to
incorporate the structural variations necessary for
obtaining new antiinflammatory drugs.
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